TM
GH icon

Triatomic Management’s Guardant Health GH Stock Holding History

Triatomic Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100,000
Closed -$2.34M – 58
2023
Q1 		$2.34M Buy
+100,000
New +$2.86M 1.58% 12

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Triatomic Management's GH Position: Q1 2024 in Review

Triatomic Management sold out of Guardant Health (GH) in Q1 2024, closing a stake of 8,000 shares — an estimated $216K sold.

Triatomic Management first reported a position in GH in Q4 2021 and held it in 6 quarters. The position peaked at $2.66M in Q4 2021. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Triatomic Management reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Triatomic Management sold 8,000 Guardant Health shares in Q1 2024, an estimated $216K.
  • Triatomic Management first reported a position in Guardant Health in Q4 2021 and held it in 6 quarters.
  • Triatomic Management's Guardant Health position peaked at $2.66M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Triatomic Management's 13F filing for Q1 2024, filed 13 May 2024.